Business Wire

AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector

Jaa

AlgaEnergy, a Spanish biotechnology company specializing in the production and commercial applications of microalgae, and Yokogawa Electric Corporation (TOKYO:6841), a leading provider of industrial automation, control, and measurement technology, announce the signing of a partnership & equity participation agreement. The strategic agreement involves an approximately 10 million euro investment by Yokogawa to acquire newly issued shares of AlgaEnergy, making the Japanese company a reference shareholder.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181105006048/en/

AlgaEnergy's microalgae production facility in Cádiz, Spain (Photo: Business Wire)

AlgaEnergy's microalgae production facility in Cádiz, Spain (Photo: Business Wire)

Microalgae are a diverse group of unicellular photosynthetic micro-organisms that can thrive in a wide variety of aquatic habitats, such as oceans, lakes, and rivers. Their rapid rate of reproduction means they can be utilized effectively as a biological resource. They are recognized as having great potential to contribute to a more sustainable society through applications in diverse sectors ranging from agriculture, food, and animal feed through to pharmaceuticals, cosmetics, biomaterials and, in the future, sustainable biofuels.

AlgaEnergy has been a pioneer in the microalgae biotechnology field since 2007. It is currently operating a commercial production facility in the south of Spain, and, in late 2015, launched the world’s first line-up of microalgae-based biostimulant* products to promote efficient crop cultivation.

The entry of Yokogawa as a shareholder will enable AlgaEnergy to reinforce its position of international leadership, with the equity investment being used to fund a set of ambitious projects, including international expansion of its biostimulant product sales organization, entry into new sectors such as food and cosmetics, and development of its promising product pipeline.

However, the scope of the agreement extends beyond just financial investment. The two companies, which share strong synergies and a common vision, seek to build an industry-leading partnership in the microalgae biotechnology sector worldwide by collaborating in the areas of R&D, manufacturing, marketing, and sales. AlgaEnergy will leverage its broad knowledge and experience in the microalgae biological processes, accumulated throughout more than four decades of R&D by its scientific leader, the world-renowned microbiologist Professor Miguel Garcia Guerrero of the University of Seville. Yokogawa will provide the advanced technologies and knowhow related to automation of industrial processes that will be key for maximizing quality and efficiency as production volumes increase.

United by a commitment to sustainability

Augusto Rodríguez-Villa, AlgaEnergy’s president, highlighted that, “This agreement is the best possible partnership in the journey to achieve our mission to leverage the potential of microalgae worldwide. We share the same vision for the future, the belief that more sustainable development is possible and that microalgae can be a key contributor towards that objective.”

Tsuyoshi Abe, senior vice president and head of the Marketing Headquarters at Yokogawa, added, “Yokogawa aims to contribute directly to the UN’s Sustainable Development Goals through its core business activities, and this year we established a new Life Innovation business unit in line with that. This is our first serious foray into clean technology in the bioeconomy, which was recently added as a new focus area in our long-term business framework, so we have high expectations for this exciting strategic partnership.”

*  

Biostimulant: substance or micro-organisms whose function when applied to plants or the surrounding soil is to stimulate natural processes to enhance nutrient uptake, nutrient efficiency, tolerance to abiotic stress, and crop quality.

 

About AlgaEnergy

AlgaEnergy is a biotechnology company specialized in the science of microalgae. The company consolidates over four decades of state-of-the-art knowledge related to microalgae, generated by the main specialized universities, and has invested heavily in applied R&D, positioning itself as the main international reference in this field. AlgaEnergy’s mission is to develop and commercialize innovative, high-quality products derived from microalgae, targeting specific needs in different industries.
For more information about AlgaEnergy, please visit www.algaenergy.es/en/

About Yokogawa

Founded in 1915, Yokogawa engages in broad-ranging activities in the areas of measurement, control, and information. The industrial automation business provides vital products, services, and solutions to a diverse range of process industries including oil, chemicals, natural gas, power, iron and steel, and pulp and paper. With the life innovation business the company aims to radically improve productivity across the pharmaceutical and food industry value chains. The test & measurement, aviation, and other businesses continue to provide essential instruments and equipment with industry-leading precision and reliability. Yokogawa co-innovates with its customers through a global network of 113 companies spanning 61 countries, generating US$3.8 billion in sales in FY2017.
For more information, please visit www.yokogawa.com.

The names of corporations, organizations, and products herein are either trademarks or registered trademarks of their respective holders.

Contact information

Yokogawa Electric Corporation
Philip Lewis
Public Relations Manager
Yokogawa-pr@cs.jp.yokogawa.com
2-9-32 Nakacho
Musashino-shi
Tokyo
Japan 180-8750
Tel: +81 422-52-5530
or
AlgaEnergy
Fernando Varés Orive
Communications Manager
fvo@algaenergy.es
Avenida de Europa, 19
Parque Empresarial “La Moraleja”
28108 Alcobendas, Madrid
Spain
Tel: +34 91-490-2020

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.21.1.2019 17:05Tiedote

ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer’s nose. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005035/en/ AirFit N30i nasal CPAP mask, front view (Photo: Business Wire) The top-of-head connection keeps tubing out of the wearer’s way, letting them move and sleep in any position. The nasal cradle cushion – ResMed’s first – is designed to reduce facial markings and irritation. AirFit N30i is also convenient for equipment providers and sleep labs – it fits 96 percent of PAP users with just two frame sizes and four cushion sizes. How AirFit N30i compares to the market-leading nasal top-of-head mask In side-by-side comparisons, three out of four users preferred AirFit N30i over the other nasal mask with a top-of-head connection. A majority stated they loved

Metabolon Appoints Michael Rasche as President of International Business21.1.2019 16:06Tiedote

Metabolon, the world leader in metabolomics, today announced that Michael Rasche joined the company as President of International Business. Michael will report to Rohan Hastie, Metabolon’s President and CEO, and become a member of the corporate executive team. He will lead all of Metabolon's international business activities with a strong focus on customer and team expansion. "We are thrilled to have Michael join the Metabolon team," said Hastie. "Michael brings a wealth of commercial and business experience across multiple areas of life sciences, from Pharma to Diagnostics and Biotech. I know he will make an immediate impact on our existing and future customers." "I am very excited to become part of the Metabolon success story," added Rasche. "I will passionately lead our team to drive accelerated business expansion across all international markets. Our Precision Metabolomics™ technology is delivering biomarker discoveries, innovative diagnostic tests, and groundbreaking data in genom

AMCS Announces Acquisition of Recy Systems21.1.2019 16:00Tiedote

AMCS, the world’s leading supplier of integrated software and vehicle technology for the waste and recycling sector, has today announced the acquisition of Germany's leading recycling and waste management software specialist, Recy Systems (Recy). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005193/en/ Recy has offices in Germany, U.S., U.K. and Slovakia. Their customers include some of the world’s largest and most complex recycling companies. Overall, the acquisition will add another 600 customers from across Europe, in North America, Asia, and Africa, taking AMCS’ total customer base to over 2400 worldwide. In addition to growing AMCS’ market share in the high-growth German market, the acquisition will support its continued development of a best-in-class global solution for the metal recycling industry. It will also contribute to the development of the company’s platform used by the wider waste, recycling and resour

Anticipation Builds as MWC19 Barcelona Approaches21.1.2019 12:00Tiedote

The GSMA today announced final updates for MWC19 Barcelona (formerly Mobile World Congress), including additional keynote speakers, participating companies, programmes and events. Taking place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet, MWC19 Barcelona is set to attract more than 107,000 professionals from over 200 countries and territories. “With the anticipated arrival of 5G, this year’s event is set to be one of the most exciting as the industry convenes to showcase Intelligent Connectivity across new technologies on the brink of reaching millions of people across the world,” said John Hoffman, CEO, GSMA Ltd. “Over the four days of MWC19, attendees will have the opportunity to hear from leaders who are driving innovation and we look forward once again to welcoming the mobile world to Barcelona.” Global Leaders to Keynote The GSMA announced the addition of several new keynote speakers for MWC19 including executives from lea

Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease21.1.2019 12:00Tiedote

Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. “Today’s approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ‘‘By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.’’ The label update is based on data from a Phase 3 open-label safety study in 60 patients that showed treatment with lumacaftor/ivacaftor was generally well tolerated for 24 weeks, with a safety profile in these pediatric patients generally consistent with

B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution21.1.2019 12:00Tiedote

B2C2, one of the largest cryptocurrency liquidity providers and the leader in electronic OTC trading, today announced the launch of streaming pricing with point-and-click execution on its OTC platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005063/en/ Max Boonen, Founder and CEO of B2C2 (Photo: Business Wire) For the first time, B2C2’s clients will be able to view and execute trades on a real-time two-way market, via the firm’s secure web interface. The new functionality allows market participants to easily monitor live pricing in user-defined quantities and execute with the click of a button, as they would on traditional FX trading platforms. The launch rounds out a number of milestones for B2C2 in 2018, including surpassing 2017 peak volumes; rolling out a completely redesigned front-end; forming integration partnerships with the major liquidity hubs; and launching a research offering. Founded in 2015, B2C2 i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme